Skip to content

Clinical trials

Phase 3 Alzheimer Disease trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 3 Country / region: Denmark Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20061
20081
20101
20121
20131
20142
20151
20162
20171
20181
20191
20203
20212
20221
20231
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated10
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche9
Biogen2
Eidos Therapeutics, a BridgeBio company2
H. Lundbeck A/S2
Novo Nordisk A/S2
AriBio Co., Ltd.1
AstraZeneca1
Eli Lilly and Company1
Myrexis Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease25
Dementia3
Amyloid Neuropathies, Familial2
Amyloidosis2
Cardiomyopathies2
Cognitive Dysfunction2
Heart Diseases2
Brain Diseases1
Central Nervous System Diseases1
Delirium1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.